Several studies have suggested that patients with diabetes and CKD have higher levels of ET-1, reflecting coincidental endothelial and renal dysfunction that can lead to vascular remodeling and ultimately, ischemic nephropathy and PAD [36–43]. This evidence concerns the gene EDN1 and chronic kidney disease.